Music therapy for mood disturbance during hospitalization for autologous stem cell transplantation : A randomized controlled trial
โ Scribed by Barrie R. Cassileth; Andrew J. Vickers; Lucanne A. Magill
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 95 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
BACKGROUND
Highโdose therapy with autologous stem cell transplantation (HDT/ASCT) is a commonly used treatment for hematologic malignancies. The procedure causes significant psychological distress and no interventions have been demonstrated to improve mood in these patients. Music therapy has been shown to improve anxiety in a variety of acute medical settings. In the current study, the authors determined the effects of music therapy compared with standard care on mood during inpatient stays for HDT/ASCT.
METHODS
Patients with hematologic malignancy admitted for HDT/ASCT at two sites (Memorial SloanโKettering Cancer Center and Ireland Cancer Center in Cleveland, Ohio) were randomized to receive music therapy given by trained music therapists or standard care. Outcome was assessed at baseline and every 3 days after randomization using the Profile of Mood States.
RESULTS
Of 69 patients registered in the study, followโup data were available for 62 (90%). During their inpatient stay, patients in the music therapy group scored 28% lower on the combined Anxiety/Depression scale (P = 0.065) and 37% lower (P = 0.01) on the total mood disturbance score compared with controls.
CONCLUSIONS
Music therapy is a noninvasive and inexpensive intervention that appears to reduce mood disturbance in patients undergoing HDT/ASCT. Cancer 2003;98:2723โ9. ยฉ 2003 American Cancer Society.
๐ SIMILAR VOLUMES
## Abstract One hundred and fiftyโseven patients undergoing highโdose chemotherapy (HDT) and autologous stemโcell transplantation (ASCT) for hematopoietic malignancies and solid tumors were randomly assigned to receive (Group A) or not (Group B) prophylaxis with ciprofloxacin, orally, and vancomyci